Alpha Paradigm Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$1.51M Buy
2022
Q2
Sell
2022
Q1
$683K Sell
2021
Q4
$991K Sell
2021
Q3
$1.49M Buy